Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 123635
Published online Aug 15, 2026. doi: 10.4239/wjd.123635
Published online Aug 15, 2026. doi: 10.4239/wjd.123635
Table 3 Comparison of plasma biochemical parameters between the control and observation group
| Indicators | Control group | Observation group | Z/χ2 | P value |
| Number of cases | 222 | 222 | ||
| Triglyceride (mmol/L) | 2.80 (2.00-3.91) | 4.35 (2.42-5.73) | 6.871 | 0.000 |
| Total cholesterol (mmol/L) | 5.87 (4.30-7.33) | 6.11 (4.53-7.44) | 1.031 | 0.303 |
| HDL-C (mmol/L) | 1.61 (1.37-1.83) | 1.53 (1.18-1.84) | -2.126 | 0.034 |
| LDL-C (mmol/L) | 3.32 (2.37-4.02) | 4.26 (3.90-4.56) | 11.581 | 0.000 |
| Fasting blood glucose (mmol/L) | 4.28 (3.88-4.73) | 4.76 (4.12-5.53) | 7.482 | 0.000 |
| Glycated hemoglobin (%) | 5.40 (5.40-5.60) | 6.50 (6.10-6.90) | 15.545 | 0.000 |
- Citation: Xu XP, Ding S, Che YM, Li J, Zhang Z, Qian C. Expression and clinical value of the plasma peroxiredoxin family in early pregnancy for predicting subsequent gestational diabetes mellitus. World J Diabetes 2026; 17(8): 123635
- URL: https://www.wjgnet.com/1948-9358/full/v17/i8/123635.htm
- DOI: https://dx.doi.org/10.4239/wjd.123635